Impact of a recent lead recall on utilization of implantable cardioverter defibrillators: Data from the NCDR ICD registry™

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 8, 2012, Pages 861-865

  Bhatt, Paras ^a   Curtis, Jeptha ^a   Wang, Yongfei ^a   Lampert, Rachel ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

implantable cardioverter defibrillator; lead fracture; Medtronic Fidelis; recall; sudden cardiac death

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DEFIBRILLATOR; DEVICE RECALL; FEMALE; HEART DEATH; HUMAN; IMPLANT REGISTRY; IMPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; SECONDARY PREVENTION;

AGED; AGED, 80 AND OVER; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MEDICAL DEVICE RECALLS; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PRIMARY PREVENTION; PROSTHESIS DESIGN; PROSTHESIS FAILURE; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84866118513     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02310.x     Document Type: Article

References (31)

1. Goldberger Z, Lampert R,: Implantable cardioverter-defibrillators: Expanding indications and technologies. JAMA 2006; 295: 809-818.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,; Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
3. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,; Multicenter Automatic Defibrillator Implantation Trial II Investigators: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
4. Goldenberg I, Gillespie J, Moss AJ, Hall WJ, Klein H, McNitt S, Brown MW, Cygankiewicz I, Zareba W,; Executive Committee of the Multicenter Automatic Defibrillator Implantation Trial II: Long-term benefit of primary prevention with an implantable cardioverter-defibrillator: an extended 8-year follow-up study of the Multicenter Automatic Defibrillator Implantation Trial II. Circulation 2010; 122: 1265-1271.
5. Curtis LH, Al-Khatib SM, Shea AM, Hammill BG, Hernandez A, Schulman KA,: Sex differences in the use of implantable cardioverter-defibrillators for primary and secondary prevention of sudden cardiac death. JAMA 2007; 298: 1517-1524.
6. Hernandez AF, Fonarow GC, Liang L, Al-Khatib SM, Curtis LH, LaBresh KA, Yancy CW, Albert NM, Peterson ED,: Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA 2007; 298: 1525-1532.
7. Cannom DS, Fisher J,: The Fidelis recall: How much pressure can the ICD world bear? PACE 2008; 31: 1233-1235.
8. Stiles S,: 2007. Perceptions and misconceptions: Are device recalls holding back the growth of ICD therapy? January 25.http://www.theheart.org/ article/821513
9. Medtronic press release 2007. Medtronic voluntarily suspends distribution of Sprint Fidelis defibrillation leads. January 25. http://wwwp.medtronic.com/ Newsroom/NewsReleaseDetails.do?itemId=1192213397218&lang=en-US/
10. Ellenbogen KA, Wood MA, Swerdlow CD,: The Sprint Fidelis lead fracture story: What do we really know and where do we go from here? Heart Rhythm 2008; 5: 1380-1381.
11. Henrikson CA,: The Sprint Fidelis story: Where are we now? Heart Rhythm 2009; 6: 611-612.
12. Maisel WH, Hauser RG, Hammill SC, Ellenbogan KA, Epstein AE, Hayes DL, Alpert JS, Berger RD, Curtis AB, Dubin AM, Estes NA 3rd, Gura MT, Krahn AD, Lampert R, Lindsay BD, Wilkoff BL,; Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines; American College of Cardiology (ACC); American Heart Association (AHA): Recommendations from the Heart Rhythm Society Task Force on lead performance policies and guidelines. Heart Rhythm 2009; 6: 869-885.
13. Reuters. New York Times A, 2008, 2009. Cost-cutting lifts Medtronic's earnings. January 25. http://www.nytimes.com/2008/08/20/business/20device.html? scp=25&sq=medtronic%20fidelis&st=cse
14. Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, Mirro MJ, Radford MJ, Wang Y, Curtis JP, Lang CM, Harder JC, Brindis RG,: Review of the Registry's second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm 2008; 5: 1359-1363.
15. Box G, Jenkins G, Reinsel G,: Time Series Analysis, Forecasting and Control, 3rd edition. 1994, Englewood Cliffs, NJ: Prentice Hall. pp. 197-199.
16. Maisel WH, Hauser RG,: Proceedings of the ICD Lead Performance Conference. Heart Rhythm 2008; 5: 1331-1338.
17. Altman LNYTO, 2007 2007. Heart device recall poses a quandary for patients. January 25, 2011. http://www.nytimes.com/2007/10/16/business/ 16patient.html?-r=1
18. Burton TM, Mathews AW,: Medtronic recall exposes gaps in medical safety. Spotty data and testing left FDA in the dark; firm cites five deaths. Wall Street Journal; October 30, 2007.
19. Chicago Tribune News Service. October 15 2007. Doctors warned of faulty defibrillator wires. January 25. http://pqasb.pqarchiver.com/chicagotribune/ access/1364847601.html?FMT=ABS&FMTS=ABS:FT&type=current&date= Oct+15%2C+2007&author=&pub=Chicago+Tribune&edition=&startpage= 9&desc=Doctors+warned+of+faulty+defibrillator+wires
20. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA, 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Buller CE, Creager MA, Ettinger SM, Faxon DP, Halperin JL, Hiratzka LF, Hunt SA, Krumholz HM, Kushner FG, Lytle BW, Nishimura RA, Ornato JP, Page RL, Riegel B, Tarkington LG, Yancy CW,; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons: ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408.
21. Carlson MD, Wilkoff BL, Maisel WH, Carlson MD, Ellenbogen KA, Saxon LA, Prystowsky EN, Alpert JS, Cain ME, Ching EA, Curtis AB, Davies DW, Hammill SC, Hauser RG, Lampert R, Zipes DP,; American College of Cardiology Foundation; American Heart Association; International Coalition of Pacing and Electrophysiology Organizations: Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electrophysiology Organizations (COPE). Heart Rhythm 2006; 3: 1250-1273.
22. Urgent Medical Device Information: Sprint Fidelis Lead Patient Management Recommendations. Minneapolis, MN: Medtronic, Inc., October 15, 2007.3/22/11. http://www.medtronic.sk/fidelis/FidelisPhysicianLetterFinal-Print-10 - 11.pdf
23. Hauser RG, Hayes DL,: Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure. Heart Rhythm 2009; 6: 605-610.
24. Maytin M, Love CJ, Fischer A, Carrillo RG, Garisto JD, Bongiorni MG, Segreti L, John RM, Michaud GF, Albert CM, Epstein LM,: Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter-defibrillator lead. J American College of Cardiology 2010; 56: 646-650.
25. Keren A, Sears SF, Nery P, Shaw J, Green MS, Lemery R, Gollob MH, Amyotte B, Birnie DH,: Psychological adjustment in ICD patients living with advisory fidelis leads. J Cardiovasc Electrophysiol 2011; 22: 57-63.
26. Pedersen SS, van den Berg M, Theuns DA,: A viewpoint on the impact of device advisories on patient-centered outcomes. Pacing Clin Electrophysiol 2009; 32: 1006-1011.
27. Maisel WH, Moynahan M, Zuckerman BD, Gross TP, Tovar OH, Tillman DB, Schultz DB,: Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 2006; 295: 1901-1906.
28. Maisel WH,: Pacemaker and ICD generator reliability: Meta-analysis of device registries. JAMA 2006; 295: 1929-1934.
29. Steinbrook R,. The controversy over Guidant's implantable defibrillators. N Engl J Med 2005; 353: 221-224.
30. Al-Khatib SM, Hellkamp A, Curtis J, Mark D, Peterson E, Sanders G, Heidenreich PA, Hernandez AF, Curtis LH, Hammill S,: Non-evidence-based ICD implantations in the United States. JAMA 2011; 305: 43-49.
31. Chen J, Normand SL, Wang Y, Krumholz HM,: National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 2011; 306: 1669-1678.